Mark McHale Email & Phone Number
Chief Scientific Officer
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark McHale Location
- United Kingdom
Mark McHale Work
- Chief Scientific Officer @ Oak Hill Bio (January 2022 - Present)
- Chief Operating Officer @ TheraMyc Limited (June 2020 - January 2022)
- Head R and D, Chief Development Officer @ ASLAN Pharmaceuticals Singapore (February 2019 - June 2020)
- Chief Operating Officer @ ASLAN Pharmaceuticals (February 2014 - June 2020)
- Chief Scientific Officer @ ASLAN Pharmaceuticals (February 2011 - June 2020)
- siRNA Inhalation Delivery Project Leader @ (June 2009 - February 2011)
- AZ and Dynavax TLR9 Collaboration Leader @ (May 2007 - February 2011)
- Senior Project Leader @ AstraZeneca R&D (January 2007 - February 2011)
- Head Molecular Sciences Respiratory and Inflammation @ (January 2001 - December 2009)
- Team Leader Respiratory and Inflammation @ (June 1997 - September 2001)
- Senior Scientist Neuroscience @ (April 1994 - June 1997)
- Senior Project Leader @ AstraZeneca R&D
- Post Doctoral Research Fellow @ Professor Sydney Brenner Molecular Genetics Unit Cambridge UK (January 1992 - June 1993)
- Senior Scientist Biotechnology @ (January 1991 - December 1994)
- Post Doctoral Research Fellow with Professor Richard Oliver @ (March 1990 - January 1991)
- PhD with Professor Richard Oliver @ (January 1986 - January 1989)
Mark McHale Education
- University of East Anglia
PhD (Molecular Biology)
1986-1989 - University of London
BSc (first class honours) (Genetics with Molecular Biology)
1983-1986
Mark McHale Skills
- Drug Discovery
- Clinical Development
- Pharmaceutical Industry
- Pharmacology
- Lifesciences
- Drug Development
- Biotechnology
- Clinical Trials
- Oncology
- CRO
- Biomarkers
- Immunology
- GCP
- Molecular Biology
- Infectious Diseases
- Medicinal Chemistry
- Cell Biology
- Neuroscience
- Science
- Biochemistry
- GLP
- Life Sciences
- Toxicology
- Clinical Research
- Biopharmaceuticals
- Genetics
- Leadership
- Data Analysis
- Change Management
- Teaching
- Healthcare
- Microsoft Excel
Mark McHale Summary
- Mark McHale, based in United Kingdom, is currently a Chief Scientific Officer at Oak Hill Bio. Mark McHale brings experience from previous roles at TheraMyc Limited, ASLAN Pharmaceuticals Singapore and ASLAN Pharmaceuticals. Mark McHale holds a 1986 - 1989 PhD in Molecular Biology @ University of East Anglia. With a robust skill set that includes Drug Discovery, Clinical Development, Pharmaceutical Industry, Pharmacology, Lifesciences and more. Mark McHale has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark McHale?
Find contact details for 700 million professionals.
Others Named Mark McHale
Mark McHale
Chief Scientific Officer
United Kingdom
Mark McHale
Planning Manager
United Kingdom
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co